Yeoungjee Cho,Aminu K. Bello,Adeera Levin,Meaghan Lunney,Mohamed A. Osman,Feng Ye,Gloria E. Ashuntantang,Ezequiel Bellorin-Font,Mohammed Benghanem Gharbi,Sara N. Davison,Mohammad Ghnaimat,Paul Harden,Htay,Vivekanand Jha,Kamyar Kalantar-Zadeh,Peter G. Kerr,Scott Klarenbach,Csaba P. Kovesdy,Valerie Luyckx,Brendon Neuen,Donal O'Donoghue,Shahrzad Ossareh,Jeffrey Perl,Harun Ur Rashid,Eric Rondeau,Emily J. See,Syed Saad,Laura Sola,Irma Tchokhonelidze,Vladimir Tesar,Kriang Tungsanga,Rumeyza Turan Kazancioglu,Angela Yee-Moon Wang,Chih-Wei Yang,Alexander Zemchenkov,Ming-Hui Zhao,Kitty J. Jager,Fergus J. Caskey,Kailash K. Jindal,Ikechi G. Okpechi,Marcello Tonelli,David C. Harris,David W. Johnson

Abstract:Rationale & Objective: Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe. Study Design: A cross-sectional survey. Setting & Participants: Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018. Outcomes: PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures. Analytical Approach: Descriptive statistics. Results: Responses were received from 88% (n = 160) of countries and there were 313 participants (257 nephrologists [82%], 22 nonnephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n = 156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/ 22). In 69% of countries, PD was the initial dialysis modality for <= 10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes. Limitations: Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data. Conclusions: Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.

Peritoneal Dialysis Use and Practice Patterns: an International Survey Study.